CX3CL1 and non-small cell lung carcinoma: Further genetic inhibition of CX3CL1 in VBMECs or of CX3CR1 in A549 cells consistently reduced the expression of MMP-2 and MMP-9 in NSCLC cells, abolishing the alterations mediated by VBMECs.